Parasitic infections are infections caused by small organisms like bacteria, viruses, fungi, parasites, and protozoa. These organisms can live inside or on the surface of the human body and cause a variety of effects, ranging from mild discomfort to severe illnesses and death. Parasitic infections are very common, with more than 3.5 billion people affected worldwide. The most common type of parasitic infection is protozoa, which is a single-celled organism. These organisms can enter the human body through contact with contaminated water, food, soil, fleas, or other animals. Many types of protozoan infections exist, including malaria and amebiasis. Another type of parasitic infection is helminths, which are larger parasites that can enter the body through the ingestion of contaminated food or water. Types of helminthic infections include hookworm and trichinosis. These parasites can cause serious diseases, such as anemia and malnutrition. Parasitic infections can also cause irritation to the skin and the mucous membranes of the respiratory system, such as the nose, throat, and lungs. Common skin parasitic infections include scabies, head lice, and body lice. Respiratory parasitic infections like bronchitis, asthma, and pneumonia, are usually caused by parasites like roundworms and tapeworms. Diagnosis and treatment for parasitic infections vary widely and depend on the type of infection and the severity of symptoms. Common treatments for mild infections include hygiene measures, such as thorough washing of hands and clothing, as well as the use of antimicrobial drugs. For severe infections, additional treatment with more powerful medications may be required. In general, it is important to take measures for good hygiene to minimize the risk of parasitic infections. Proper handwashing and hygiene in the home are simple yet very effective steps to prevent the spread of parasitic diseases. If you notice any signs or symptoms of a parasitic infection, seek medical attention as soon as possible.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States